EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Proteomics Reveals Quantitative Differences in Low-Abundance Glycosyltransferases of Patients with Congenital Disorders of Glycosylation

Roman Sakson iD, Lars Beedgen, Patrick Bernhard iD, K Merve Alp iD, Nicole Lübbehusen, Ralph Röth, Beate Niesler, Marcin Luzarowski, Olga Shevchuk iD, Matthias P Mayer, Christian Thiel, Thomas Ruppert iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25021191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Roman Sakson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany. Hauptthemen laut MEDLINE: Glycosyltransferases, Congenital Disorders of Glycosylation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein glycosylation is an essential post-translational modification in all domains of life. Its impairment in humans can result in severe diseases named congenital disorders of glycosylation (CDGs). Most of the glycosyltransferases (GTs) responsible for proper glycosylation are polytopic membrane proteins that represent challenging targets in proteomics. We established a multiple reaction monitoring (MRM) assay to comprehensively quantify GTs involved in the processes of N-glycosylation and O- and C-mannosylation in the endoplasmic reticulum. High robustness was achieved by using an enriched membrane protein fraction of isotopically labeled HEK 293T cells as an internal protein standard. The analysis of primary skin fibroblasts from eight CDG type I patients with impaired ALG1, ALG2, and ALG11 genes, respectively, revealed a substantial reduction in the corresponding protein levels. The abundance of the other GTs, however, remained unchanged at the transcript and protein levels, indicating that there is no fail-safe mechanism for the early steps of glycosylation in the endoplasmic reticulum. The established MRM assay was shared with the scientific community via the commonly used open source Skyline software environment, including Skyline Batch for automated data analysis. We demonstrate that another research group could easily reproduce all analysis steps, even while using different LC-MS hardware.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycosyltransferasesCongenital Disorders of GlycosylationHumansGlycosylationProteomicsProtein Processing, Post-TranslationalMembrane ProteinsMannosyltransferases

Stichwörter der Autor:innen

MRMSkylinecongenital disorders of glycosylationendoplasmic reticulumglycosylationnCounterproteomics

Substanzen

GlycosyltransferasesMembrane ProteinsALG11 protein, humanMannosyltransferases

Autor:innen und Institutionen

  • Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.
  • Heidelberg Biosciences International Graduate School (HBIGS), Heidelberg University, 69120 Heidelberg, Germany.
  • Center for Child and Adolescent Medicine, Department Pediatrics I, Heidelberg University, 69120 Heidelberg, Germany.
  • Institute for Surgical Pathology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125 Berlin, Germany.
  • nCounter Core Facility, Institute of Human Genetics, University Hospital Heidelberg, 69120 Heidelberg, Germany.

ORCID-Profile: Roman Sakson, Patrick Bernhard, K Merve Alp, Olga Shevchuk, Thomas Ruppert

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Sakson, R., Beedgen, L., Bernhard, P., Alp, K. M., Lübbehusen, N., Röth, R., Niesler, B., Luzarowski, M., Shevchuk, O., Mayer, M. P., Thiel, C., & Ruppert, T. (2024). Targeted Proteomics Reveals Quantitative Differences in Low-Abundance Glycosyltransferases of Patients with Congenital Disorders of Glycosylation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021191

Vancouver

Sakson R, Beedgen L, Bernhard P, Alp KM, Lübbehusen N, Röth R, et al. Targeted Proteomics Reveals Quantitative Differences in Low-Abundance Glycosyltransferases of Patients with Congenital Disorders of Glycosylation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021191

BibTeX
@article{Sakson2024,
  author = {Sakson, Roman and Beedgen, Lars and Bernhard, Patrick and Alp, K Merve and Lübbehusen, Nicole and Röth, Ralph and Niesler, Beate and Luzarowski, Marcin and Shevchuk, Olga and Mayer, Matthias P and Thiel, Christian and Ruppert, Thomas},
  title = {Targeted Proteomics Reveals Quantitative Differences in Low-Abundance Glycosyltransferases of Patients with Congenital Disorders of Glycosylation},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25021191}
}
Kostenlos starten →